Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients.
about
Tacrolimus does not affect early wound healing in a rodent model of bowel anastomoses and abdominal wall closure.Incidence and risk factors of incisional hernia formation following abdominal organ transplantation.Sirolimus and mycophenolate mofetil as GVHD prophylaxis in myeloablative, matched-related donor hematopoietic cell transplantationCardiac allograft vasculopathy: a donor or recipient induced pathology?Everolimus: an immunosuppressive agent in transplantation.Emerging drugs in lung transplantation.Risk factors for impaired wound healing in sirolimus-treated renal transplant recipients.Defects in skin gamma delta T cell function contribute to delayed wound repair in rapamycin-treated miceThe first year post-heart transplantation: use of immunosuppressive drugs and early complications.AGEs Induced Autophagy Impairs Cutaneous Wound Healing via Stimulating Macrophage Polarization to M1 in DiabetesSurgical wound complications after heart transplantation.Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions.Proliferation signal inhibitor toxicities after thoracic transplantation.Endothelial dysfunction and cardiac allograft vasculopathy.Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives.Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature.Impaired lower extremity wound healing secondary to sirolimus after kidney transplantation.Nosocomial infections within the first month of solid organ transplantation.Safety of mTOR inhibitors in adult solid organ transplantation.mTOR Inhibition by Everolimus Does Not Impair Closure of Punch Biopsy Wounds in Renal Transplant Patients.Treatment and prevention of cytomegalovirus infection in heart and lung transplantation: an update.Postoperative complications associated with perioperative sirolimus prior to pediatric cardiac retransplantation.Conversion from calcineurin inhibitors to mTOR inhibitors as primary immunosuppressive drugs in pediatric heart transplantation.The Effect of Mycophenolate Mofetil on Early Wound Healing in a Rodent Model.A hospital-to-home evaluation of an enhanced recovery protocol for elective pancreaticoduodenectomy in China: A cohort study.The utilization of sirolimus and the impact on wound-healing complications in obese kidney transplant recipients.Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice.Sirolimus and intraoperative hyperthermic peritoneal chemoperfusion with mitomycin-C do not impair healing of bowel anastomoses.Safety of mTOR inhibitor continuation in pediatric heart transplant recipients undergoing surgical procedures.Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients: Results of the Prospective Randomized Study EVERHEART.Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing.Preliminary report of major surgery in liver transplant recipients receiving m-TOR inhibitors without therapeutic discontinuation.The Past, Present and Future of Heart Transplantation.Everolimus-induced loss of wound strength can be prevented by a short postoperative delay in its administration
P2860
Q35006318-C616CE57-3416-4EDA-9AFF-6F0441ED1BDDQ35073258-8EB67D2F-21A4-4A55-B378-7A6E1662F9B6Q35184589-9717CE5F-26BE-45B2-ADDC-ED9E6046EF5BQ35244151-B2FEA71F-F1F8-49E4-A3DE-444BAE6E9B64Q36521866-00CB32D7-C449-4BEE-88B1-BA94BD1DE40BQ36758582-850A4268-BC75-41DA-908B-2CA61F229B89Q36889289-5BBC35FC-937C-4900-8698-8F2C2EAD8E56Q36899362-A39BD4BB-460B-4C8A-86E5-80CC9B46EECBQ37089563-4B0993C9-116F-4C66-926A-540D72CB391EQ37386368-967F4C85-EA23-484A-AF46-DE6C223FF5A0Q37854845-FAFF974D-120A-4389-97FE-1D9D76DEF8BEQ37876951-9AA9FD40-47FA-4CF5-8B4E-194663DA434DQ38044748-E103E988-C02A-4B91-8A17-55F0B28EF0CDQ38058477-B0A8F637-40C3-4BFD-AC6D-D9FA220B74EDQ38068585-8208B554-CA30-42C4-8261-A90E4B67133EQ38131036-5865C240-ECA7-4476-928F-712FE648FDDBQ38187974-A049A457-F309-4AA0-89D0-51C779002E1AQ38198772-04B91343-B212-451C-90C0-9AA2691B1ADEQ38669190-EEE76F48-63AF-4B29-B151-882D4E415B72Q38839083-501673B8-4F1C-458B-AB89-23498D3E622BQ38875887-AF69559C-2179-45F7-9794-73E3028AF557Q38954484-0B7A151E-2CC7-4790-9A10-AFA113FB450EQ40134753-B342A8B6-AC98-43F2-AA9B-4E18D6EC5BF8Q42156439-F07B724A-954E-48C5-97E6-574FC8552F73Q43365850-AE7682BE-A1D7-4A0E-B282-25940DE5DD75Q44343260-2124B5CA-C23A-4677-8624-4C2B9649DB0DQ46231960-2D12A8A0-208D-44F0-904D-6210EFA4A418Q46787464-6B76CA05-8A25-4D51-9BC6-E718DCA4A23EQ47279703-CEC1199D-1AE6-41E1-976B-A07C851A7C9BQ49990142-D8D114AF-ED81-4184-A81E-41794466DBC9Q50610813-DE6C4395-C87E-4764-8A19-EEB121448364Q54335179-89782560-72F1-40DF-9AC7-DE03E0056C15Q55437542-00909ABC-5AFE-47B7-8E97-3F524D85A832Q57119713-EE6A78BE-9FC1-4AFF-9A9E-89DEBC217597
P2860
Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Wound healing complications wi ...... cardiac transplant recipients.
@en
Wound healing complications wi ...... cardiac transplant recipients.
@nl
type
label
Wound healing complications wi ...... cardiac transplant recipients.
@en
Wound healing complications wi ...... cardiac transplant recipients.
@nl
prefLabel
Wound healing complications wi ...... cardiac transplant recipients.
@en
Wound healing complications wi ...... cardiac transplant recipients.
@nl
P2093
P2860
P1476
Wound healing complications wi ...... cardiac transplant recipients.
@en
P2093
A Al-Khaldi
D Weisshaar
H A Valantine
R C Robbins
S Kuppahally
P2860
P304
P356
10.1111/J.1600-6143.2006.01282.X
P407
P433
P577
2006-05-01T00:00:00Z